Skip navigation
Speakers

Limit Study Variability • Streamline Data Collection • Ensure Efficient CEC Review • Minimize Regulatory Approval Timelines

May 1-2, 2018
  • Philadelphia, PA

Maria Ali
Global Head,
Medical and Regulatory Services and Scientific Leadership
George Clinical

Kim Brown, RN
C5R CEC Manager, Research Programs
Cleveland Clinic

Bernard R. Chaitman, MD
Professor of Medicine, Director of Cardiovascular Research and
Core ECG/Cardiovascular End-Point Laboratory
St. Louis University

Mads Engelmann, MD, PhD
International Medical Vice President
Novo Nordisk A/S

Andrew Farb, MD
Medical Officer, Senior Reviewer
US Food and Drug Administration

Jennifer Goldsack
Clinical Project Manager
Clinical Trials Transformation Initiative (CTTI)

Svetlana Gorodetsky
Vice President, Sales
IBM Watson Health

Abraham Gutman
President and CEO
AG Mednet

Alisa Hummings
Senior Director, Clinical Endpoint Validation and Adjudication
IQVIA

James L. Januzzi, Jr., MD, FACC, FESC
Hutter Family Professor of Medicine, Harvard Medical School;
Physician, Cardiology Division, Massachusetts General Hospital;
Cardiometabolic Trials, Baim Institute for Clinical Research

W. Schuyler Jones, MD
Faculty Assistant Director, Duke Clinical Research Institute, Integrated Clinical Events-Safety Surveillance
Duke University and Durham VA Medical Center

Terry Katz
Director, Global Data Management and Statistics
Merck Animal Health

Shaena Kauffman
Endpoint Adjudication Committee Lead, Director of Project Management
ACI Clinical

Craig McLendon
Senior Director, Adjudication and DMC Management
ICON plc

Lynn Perkins
Assistant Director, CEC
Duke Clinical Research Institute

Christian Ruff
Physician, Cardiology
Brigham and Women’s Hospital

Lakshmi Sundar
Business Transformation Leader
ACI Clinical

Haifa Tyler
Associate Director, GPV, Medical Safety
Otsuka Pharmaceutical Development & Commercialization, Inc.

Catherine Tyner
Executive Director, Drug Safety and Adjudication Services
Covance

Keith Usiskin
Executive Director
Celgene

Maria Ali
Global Head,
Medical and Regulatory Services and Scientific Leadership
George Clinical

Kim Brown, RN
C5R CEC Manager, Research Programs
Cleveland Clinic

Bernard R. Chaitman, MD
Professor of Medicine, Director of Cardiovascular Research and
Core ECG/Cardiovascular End-Point Laboratory
St. Louis University

Mads Engelmann, MD, PhD
International Medical Vice President
Novo Nordisk A/S

Andrew Farb, MD
Medical Officer, Senior Reviewer
US Food and Drug Administration

Jennifer Goldsack
Clinical Project Manager
Clinical Trials Transformation Initiative (CTTI)

Svetlana Gorodetsky
Vice President, Sales
IBM Watson Health

Abraham Gutman
President and CEO
AG Mednet

Alisa Hummings
Senior Director, Clinical Endpoint Validation and Adjudication
IQVIA

James L. Januzzi, Jr., MD, FACC, FESC
Hutter Family Professor of Medicine, Harvard Medical School;
Physician, Cardiology Division, Massachusetts General Hospital;
Cardiometabolic Trials, Baim Institute for Clinical Research

W. Schuyler Jones, MD
Faculty Assistant Director, Duke Clinical Research Institute, Integrated Clinical Events-Safety Surveillance
Duke University and Durham VA Medical Center

Terry Katz
Director, Global Data Management and Statistics
Merck Animal Health

Shaena Kauffman
Endpoint Adjudication Committee Lead, Director of Project Management
ACI Clinical

Craig McLendon
Senior Director, Adjudication and DMC Management
ICON plc

Lynn Perkins
Assistant Director, CEC
Duke Clinical Research Institute

Christian Ruff
Physician, Cardiology
Brigham and Women’s Hospital

Lakshmi Sundar
Business Transformation Leader
ACI Clinical

Haifa Tyler
Associate Director, GPV, Medical Safety
Otsuka Pharmaceutical Development & Commercialization, Inc.

Catherine Tyner
Executive Director, Drug Safety and Adjudication Services
Covance

Keith Usiskin
Executive Director
Celgene